A 2-Stage, Open-Label, Randomized, Single-Dose, Crossover Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat in Healthy Adult Subjects

Trial Profile

A 2-Stage, Open-Label, Randomized, Single-Dose, Crossover Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat in Healthy Adult Subjects

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 12 Oct 2016

At a glance

  • Drugs Entinostat (Primary)
  • Indications Breast cancer; Hodgkin's disease; Leukaemia; Malignant melanoma; Non-small cell lung cancer; Renal cancer
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Syndax Pharmaceuticals
  • Most Recent Events

    • 12 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top